Organon (NYSE: OGN) reported Q3 EPS of $0.87, $0.18 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.57 billion.

For earnings history and earnings-related data on Organon (OGN) click here.